EyeWorld Weekly, March 22, 2024 – EyeWorld
➤ Phase 3 results reported for novel glaucoma eye drop ➤ Update: preventative therapy for patients at risk for radiation retinopathy ➤ Topical drop for diabetic retinopathy does not meet endpoints in Phase 2 trial ➤ ASCRS news and events